Multiple Myeloma

Multiple Myeloma

Real-World Data on Immunotherapy for Relapsed/Refractory Multiple Myeloma

clinical topic updates
By Irene M. Ghobrial, MD

Multiple Myeloma

Supportive Care for Patients With Multiple Myeloma Who Are Undergoing Treatment With Chimeric Antigen Receptor T Cells or Bispecific Antibodies

patient care perspectives
By Saad Z. Usmani, MBBS, MD, MBA, FACP, FRCP, FASCO

Multiple Myeloma

The Role of Chimeric Antigen Receptor T-Cell Therapy and Bispecific Antibodies in Relapsed/Refractory Multiple Myeloma

expert roundtables
By Kenneth C. Anderson, MD; Carol Ann Huff, MD; Shaji K. Kumar, MD

Multiple Myeloma

Off-Study and On-Study Regimens for Relapsed Multiple Myeloma After 4 Prior Lines of Therapy

patient care perspectives
By Kenneth C. Anderson, MD

Multiple Myeloma

Newer Targets in Multiple Myeloma

clinical topic updates
By Carol Ann Huff, MD